1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Brain Health Supplements Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Brain Health Supplements Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence rate
5.2. Technological Advancements
5.3. Porter’s Five Forces Analysis
5.4. COVID-19 Impact Analysis
6. Global Brain Health Supplements Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Natural Molecules
6.3.1.1. Acetyl-L-Carnitine
6.3.1.2. Alpha-GPC
6.3.1.3. Citicoline
6.3.1.4. Others
6.3.2. Herbal Extract
6.3.2.1. Ginseng
6.3.2.2. Gingko Biloba
6.3.2.3. Curcumin
6.3.2.4. Others
6.3.3. Vitamin & Minerals
6.3.3.1. Vitamin B
6.3.3.2. Vitamin C & E
6.3.3.3. Others
6.4. Market Attractiveness Analysis, By Product Type
7. Global Brain Health Supplements Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Depression & Mood
7.3.2. Cognitive
7.3.3. Stress & Anxiety
7.3.4. Others
7.4. Market Attractiveness Analysis, By Application
8. Global Brain Health Supplements Market Analysis and Forecast, By Sales Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Sales Type, 2017–2031
8.3.1. Rx Prescription
8.3.2. OTC
8.4. Market Attractiveness Analysis, By Sales Type
9. Global Brain Health Supplements Market Analysis and Forecast, By Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Distribution Channel, 2017–2031
9.3.1. Online
9.3.1.1. Company Owned Website
9.3.1.2. Commercial Website
9.3.2. Offline
9.3.2.1. Hospital Pharmacies
9.3.2.2. Retail Pharmacies
9.4. Market Attractiveness Analysis, By Distribution Channel
10. Global Brain Health Supplements Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region
11. North America Brain Health Supplements Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Natural Molecules
11.2.1.1. Acetyl-L-Carnitine
11.2.1.2. Alpha-GPC
11.2.1.3. Citicoline
11.2.1.4. Others
11.2.2. Herbal Extract
11.2.2.1. Ginseng
11.2.2.2. Gingko Biloba
11.2.2.3. Curcumin
11.2.2.4. Others
11.2.3. Vitamin & Minerals
11.2.3.1. Vitamin B
11.2.3.2. Vitamin C & E
11.2.3.3. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Depression & Mood
11.3.2. Cognitive
11.3.3. Stress & Anxiety
11.3.4. Others
11.4. Market Value Forecast, by Sales Type, 2017–2031
11.4.1. Rx Prescription
11.4.2. OTC
11.5. Market Value Forecast, by Distribution Channel, 2017–2031
11.5.1. Online
11.5.1.1. Company Owned Website
11.5.1.2. Commercial Website
11.5.2. Offline
11.5.2.1. Hospital Pharmacies
11.5.2.2. Retail Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By Sales Type
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Brain Health Supplements Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Natural Molecules
12.2.1.1. Acetyl-L-Carnitine
12.2.1.2. Alpha-GPC
12.2.1.3. Citicoline
12.2.1.4. Others
12.2.2. Herbal Extract
12.2.2.1. Ginseng
12.2.2.2. Gingko Biloba
12.2.2.3. Curcumin
12.2.2.4. Others
12.2.3. Vitamin & Minerals
12.2.3.1. Vitamin B
12.2.3.2. Vitamin C & E
12.2.3.3. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Depression & Mood
12.3.2. Cognitive
12.3.3. Stress & Anxiety
12.3.4. Others
12.4. Market Value Forecast, by Sales Type, 2017–2031
12.4.1. Rx Prescription
12.4.2. OTC
12.5. Market Value Forecast, by Distribution Channel, 2017–2031
12.5.1. Online
12.5.1.1. Company Owned Website
12.5.1.2. Commercial Website
12.5.2. Offline
12.5.2.1. Hospital Pharmacies
12.5.2.2. Retail Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Distribution Channel
12.7.3. By Sales Type
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Brain Health Supplements Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Natural Molecules
13.2.1.1. Acetyl-L-Carnitine
13.2.1.2. Alpha-GPC
13.2.1.3. Citicoline
13.2.1.4. Others
13.2.2. Herbal Extract
13.2.2.1. Ginseng
13.2.2.2. Gingko Biloba
13.2.2.3. Curcumin
13.2.2.4. Others
13.2.3. Vitamin & Minerals
13.2.3.1. Vitamin B
13.2.3.2. Vitamin C & E
13.2.3.3. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Depression & Mood
13.3.2. Cognitive
13.3.3. Stress & Anxiety
13.3.4. Others
13.4. Market Value Forecast, by Sales Type, 2017–2031
13.4.1. Rx Prescription
13.4.2. OTC
13.5. Market Value Forecast, by Distribution Channel, 2017–2031
13.5.1. Online
13.5.1.1. Company Owned Website
13.5.1.2. Commercial Website
13.5.2. Offline
13.5.2.1. Hospital Pharmacies
13.5.2.2. Retail Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Distribution Channel
13.7.3. By Sales Type
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Brain Health Supplements Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Natural Molecules
14.2.1.1. Acetyl-L-Carnitine
14.2.1.2. Alpha-GPC
14.2.1.3. Citicoline
14.2.1.4. Others
14.2.2. Herbal Extract
14.2.2.1. Ginseng
14.2.2.2. Gingko Biloba
14.2.2.3. Curcumin
14.2.2.4. Others
14.2.3. Vitamin & Minerals
14.2.3.1. Vitamin B
14.2.3.2. Vitamin C & E
14.2.3.3. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Depression & Mood
14.3.2. Cognitive
14.3.3. Stress & Anxiety
14.3.4. Others
14.4. Market Value Forecast, by Sales Type, 2017–2031
14.4.1. Rx Prescription
14.4.2. OTC
14.5. Market Value Forecast, by Distribution Channel, 2017–2031
14.5.1. Online
14.5.1.1. Company Owned Website
14.5.1.2. Commercial Website
14.5.2. Offline
14.5.2.1. Hospital Pharmacies
14.5.2.2. Retail Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By Sales Type
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Brain Health Supplements Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Natural Molecules
15.2.1.1. Acetyl-L-Carnitine
15.2.1.2. Alpha-GPC
15.2.1.3. Citicoline
15.2.1.4. Others
15.2.2. Herbal Extract
15.2.2.1. Ginseng
15.2.2.2. Gingko Biloba
15.2.2.3. Curcumin
15.2.2.4. Others
15.2.3. Vitamin & Minerals
15.2.3.1. Vitamin B
15.2.3.2. Vitamin C & E
15.2.3.3. Others
15.3. Market Value Forecast, by Application, 2017–2031
15.3.1. Depression & Mood
15.3.2. Cognitive
15.3.3. Stress & Anxiety
15.3.4. Others
15.4. Market Value Forecast, by Sales Type, 2017–2031
15.4.1. Rx Prescription
15.4.2. OTC
15.5. Market Value Forecast, by Distribution Channel, 2017–2031
15.5.1. Online
15.5.1.1. Company Owned Website
15.5.1.2. Commercial Website
15.5.2. Offline
15.5.2.1. Hospital Pharmacies
15.5.2.2. Retail Pharmacies
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Application
15.7.3. By Sales Type
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Onnit Labs, Inc.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. Nutricia
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. Natural Alternatives International, Inc.
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. Quincy Bioscience
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. Reckitt Benckiser Group PLC
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Natrol, LLC.
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. H.V.M.N. Inc.
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
